Suppr超能文献

加利福尼亚州长期贫困地区按种族/族裔和性别的癌症发病率及趋势

Cancer Incidence and Trends in Persistent Poverty Areas of California by Race/Ethnicity and Sex.

作者信息

Movsisyan Vernon Ani S, Maguire Frances B, Ullah Ayman T, Hofer Brenda M, Parikh-Patel Arti, Wun Ted, Hussain Shehnaz K, Keegan Theresa H M

机构信息

UC Davis Health, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.

出版信息

Cancer Med. 2025 Aug;14(15):e71088. doi: 10.1002/cam4.71088.

Abstract

BACKGROUND

Although previous studies have observed the relationship between living in persistent poverty areas (PPAs) and adverse cancer outcomes, the relationship between residing in PPAs and disparities in cancer incidence rates and temporal trends by race/ethnicity and sex in California is unknown.

METHODS

We used California Cancer Registry data to identify patients diagnosed with 16 common cancers between 2006 and 2020. We calculated age-adjusted incidence rates (IRs), incidence rate ratios (IRRs), and average annual percent changes (AAPCs) to compare incidence and temporal trends in PPAs and non-PPAs in California by race/ethnicity and sex. PPA was defined as areas with a poverty rate of 20% or more for approximately 30 continuous years.

RESULTS

Male patients in PPAs had significantly higher IRRs of colorectal, liver, lung, and stomach cancers, and female patients had higher cervical, kidney, liver, and stomach cancers. Across all racial/ethnic groups, cervical and liver cancer IRRs were significantly higher, and IRRs for female breast cancer were lower in PPAs. The incidence of several cancers significantly decreased over time only in non-PPAs. Colorectal cancer and non-Hodgkin lymphoma among Hispanic residents significantly increased in PPAs (AAPC = 0.4, 1.2) and colorectal cancer decreased only in non-PPAs (AAPC = -1.4). Thyroid cancer among non-Hispanic Black residents increased only in PPAs (AAPC = 4.7).

CONCLUSION

Our findings highlight race/ethnicity and sex disparities in cancer incidence and temporal trends for PPA residents. Further research is needed to understand the specific etiological factors underlying these disparities, and to support the development of public health policies and initiatives to decrease the cancer burden in California.

摘要

背景

尽管先前的研究已经观察到生活在持续贫困地区(PPA)与不良癌症结局之间的关系,但在加利福尼亚州,居住在PPA与癌症发病率差异以及按种族/族裔和性别划分的时间趋势之间的关系尚不清楚。

方法

我们使用加利福尼亚癌症登记处的数据来识别2006年至2020年期间被诊断患有16种常见癌症的患者。我们计算了年龄调整发病率(IR)、发病率比(IRR)和平均年度百分比变化(AAPC),以比较加利福尼亚州PPA和非PPA地区按种族/族裔和性别划分的发病率和时间趋势。PPA被定义为贫困率持续约30年达到20%或更高的地区。

结果

PPA地区的男性患者患结直肠癌、肝癌、肺癌和胃癌的IRR显著更高,女性患者患宫颈癌、肾癌、肝癌和胃癌的IRR更高。在所有种族/族裔群体中,PPA地区宫颈癌和肝癌的IRR显著更高,女性乳腺癌的IRR更低。仅在非PPA地区,几种癌症的发病率随时间显著下降。西班牙裔居民中的结直肠癌和非霍奇金淋巴瘤在PPA地区显著增加(AAPC分别为0.4和1.2),而结直肠癌仅在非PPA地区下降(AAPC为-1.4)。非西班牙裔黑人居民中的甲状腺癌仅在PPA地区增加(AAPC为4.7)。

结论

我们的研究结果突出了PPA居民在癌症发病率和时间趋势方面的种族/族裔和性别差异。需要进一步研究以了解这些差异背后的具体病因,并支持制定公共卫生政策和举措以减轻加利福尼亚州的癌症负担。

相似文献

3
Breast Cancer Incidence Trends in Older US Women by Race, Ethnicity, Geography, and Stage.
JAMA Netw Open. 2025 Jun 2;8(6):e2516947. doi: 10.1001/jamanetworkopen.2025.16947.
4
Incidence Rate Trends of Breast Cancer Overall and by Molecular Subtype by Race and Ethnicity and Age.
JAMA Netw Open. 2025 Jan 2;8(1):e2456142. doi: 10.1001/jamanetworkopen.2024.56142.
5
Trends in Prostate Cancer Incidence and Mortality Rates.
JAMA Netw Open. 2025 Jan 2;8(1):e2456825. doi: 10.1001/jamanetworkopen.2024.56825.
6
Racial and Ethnic Variation in Survival in Early-Onset Colorectal Cancer.
JAMA Netw Open. 2024 Nov 4;7(11):e2446820. doi: 10.1001/jamanetworkopen.2024.46820.

本文引用的文献

1
The Context of Poverty and Cancer: Denying Human Potential.
Cancer Epidemiol Biomarkers Prev. 2024 Nov 1;33(11):1402-1404. doi: 10.1158/1055-9965.EPI-24-0953.
2
Recent Trends in Menopausal Hormone Therapy Use in the US: Insights, Disparities, and Implications for Practice.
JAMA Health Forum. 2024 Sep 6;5(9):e243135. doi: 10.1001/jamahealthforum.2024.3135.
3
Food Insecurity, Neighborhood Food Environment, and Health Disparities: State of the Science, Research Gaps and Opportunities.
Am J Clin Nutr. 2024 Mar;119(3):850-861. doi: 10.1016/j.ajcnut.2023.12.019. Epub 2023 Dec 30.
4
From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease.
J Lipid Res. 2024 Jan;65(1):100485. doi: 10.1016/j.jlr.2023.100485. Epub 2023 Dec 14.
5
Cancers Attributable to Infections in the US in 2017: A Meta-Analysis.
JAMA Oncol. 2023 Dec 1;9(12):1678-1687. doi: 10.1001/jamaoncol.2023.4273.
6
Barriers, facilitators, and priority needs related to cancer prevention, control, and research in rural, persistent poverty areas.
Cancer Causes Control. 2023 Dec;34(12):1145-1155. doi: 10.1007/s10552-023-01756-1. Epub 2023 Aug 1.
7
Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic.
J Natl Cancer Inst. 2023 Sep 7;115(9):1109-1111. doi: 10.1093/jnci/djad086.
8
The Art of Hormone Replacement Therapy (HRT) in Menopause Management.
J Pharm Pract. 2024 Jun;37(3):736-740. doi: 10.1177/08971900231167925. Epub 2023 Apr 1.
9
Disparities in cancer incidence by rurality in California.
J Natl Cancer Inst. 2023 Apr 11;115(4):385-393. doi: 10.1093/jnci/djac238.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验